Regulatory Novo Nordisk comeback stirs as Wegovy pill wins UK approval Pharmaceutical TechnologyThere are already lengthy patient waitlists for the medication on digital health platforms.Metabolic & GLP-1Read full story pharminent June 12, 2026 (Last updated: June 12, 2026) Pharmaceutical Technology There are already lengthy patient waitlists for the medication on digital health platforms. Metabolic & GLP-1 Read full story Post navigation Previous: China’s NMPA approves Akeso’s gumokimab for plaque psoriasisNext: Novartis’ $12B Avidity buy pays dividends with Phase 1/2 muscular dystrophy win Related Stories Regulatory Ultragenyx wins FDA approval for first treatment targeting root cause of GSDIa pharminent August 20, 2026 Regulatory Regeneron wins FDA approval to challenge Ipsen for rare bone disease market pharminent August 20, 2026 Regulatory FDA grants accelerated approval to Ultragenyx’s Genglycos gene therapy pharminent August 20, 2026
